Efficacy and Results of Endoscopic Gastroplasty Using Overstitch in Patients With Class I and II Obesity

Sponsor
Kaiser Clinic and Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03493620
Collaborator
(none)
60
2
2
30.8
30
1

Study Details

Study Description

Brief Summary

Obesity is a chronic disease that has grown to epidemic proportions in Brazil and throughout the world in recent years. Bariatric surgery has been the most effective method for the treatment and prophylaxis of complications caused by morbid obesity, thereby increasing the longevity and quality of life of patients. The treatment of patients with Class III obesity or higher or Class II with comorbidities is already well established with bariatric surgery being the best option. However, there is no consensus as to the best treatment in cases of Class I or II obesity without comorbidities. The objective of this research will be to make a gastric tube similar to that obtained by surgical gastroplication but using endoscopic intragastric sutures.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Device arm
  • Procedure: Sham arm
N/A

Detailed Description

The primary objective of this research will be to make a gastric tube similar to that obtained by surgical gastroplication but using endoscopic intragastric sutures. The secondary objective will be to correlate demographic, endoscopic and laboratory data with the outcomes.

This study will be carried out in two institutions. The Kaiser Clinic and Day Hospital and the Faculty of Medicine of ABC. Sixty patients will be randomly selected for treatment by Endospore Endoscopy (ESG) or as controls (only the endoscopist will know which group each patient belongs to). The draw will take place only after upper endoscopy has been carried out to avoid possible contraindications for the procedure due to injuries. Once the criteria for endoscopic evaluation have been met, randomization will be carried out in loco with the patient still sedated. Gastric Endo Sutures will be performed when the patient is randomized for Group I; Group II will be the control group. All patients will be followed up for two years by a multidisciplinary team (endoscopist, surgeon, nutritionist and psychologist). The data will be obtained during the outpatient follow-up at the Hospital Mario Covas and will include demographic (gender, age), clinical (height, weight, BMI, time after procedure, hypertension, diabetes, dyslipidemia, smoking, alcoholism) and operative data (complications).

Preparation to perform the examination/procedure: All exams will be performed with the patients within eight hours. The procedure will begin with the patient in left lateral decubitus position and under general anesthesia performed by an anesthesiologist. Endoscopic suturing will be performed with 2-0 prolene stitches until a tubular-shaped stomach is formed similar to vertical gastrectomy.

Recovery after the procedure: After this procedure and recovery from the anesthesia, all patients will only be discharged in the company of a companion. All patients will be counseled to enter in touch with the physician to report any signs or symptoms.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Multicenter Randomized Prospective Study With Sham Group to Evaluate the Efficacy and Results of Endoscopic Gastroplasty Using Overstitch in Patients With Class I and II Obesity
Actual Study Start Date :
Jan 8, 2018
Actual Primary Completion Date :
Aug 1, 2019
Actual Study Completion Date :
Aug 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Device arm

Gastric endosuturing will be performed until the entire gastric body is sutured in the form of a tube.

Procedure: Device arm
Make a gastric tube (endoscopic sleeve gastroplasty) using the Apollo Overstitch suturing device through endoscopy.

Sham Comparator: Sham arm

Group II is a control group (only the endoscopist will know which group each patient belongs to)

Procedure: Sham arm
Group II will be conducted identically to Group I except for the procedure itself, and only the endoscopist, that is the researcher, will be aware of which group each patient belongs to.

Outcome Measures

Primary Outcome Measures

  1. Weight loss [outcome will be evaluated for 2 years]

    weight in kg

Secondary Outcome Measures

  1. Weight maintenance [2 years]

    weight in kg

  2. Surgical related complications [2 years]

  3. Comorbidities [2 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Aged over 18 years,

  • BMI > 30 and < 36 kg/m2, with or without comorbidities,

  • BMI > 36 and < 40 without comorbidities

Exclusion Criteria:
  • Previous gastric surgery

  • Taking anticoagulant drugs

  • Psychiatric disorders

  • Severe esophagitis

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Medicine of ABC Santo André SP Brazil
2 Kaiser Clinic and Day Hospital São José Do Rio Preto SP Brazil

Sponsors and Collaborators

  • Kaiser Clinic and Hospital

Investigators

  • Principal Investigator: Luiz Gustavo de Quadros, MD, Kaiser Clinica and Day Hospital
  • Principal Investigator: Eduardo Grecco, MD, ABC Medical School
  • Principal Investigator: Manoel Galvao Neto, MD, ABC Medical School
  • Principal Investigator: Thiago Ferreira de Souza, PhD, ABC Medical School

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kaiser Clinic and Hospital
ClinicalTrials.gov Identifier:
NCT03493620
Other Study ID Numbers:
  • ApolloSham
First Posted:
Apr 10, 2018
Last Update Posted:
Aug 17, 2022
Last Verified:
Aug 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 17, 2022